ZYMEWORKS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.18 USD | -1.64% |
|
+10.50% | -1.73% |
| 06-17 | Zymeworks Says FDA Clears Investigational New Drug Application for Cancer Therapy | MT |
| 06-17 | Zymeworks Gets FDA OK to Study ZW171 for Mesothelin-Expressing Cancers | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZYMEWORKS INC. | Bio Therapeutic Drugs | -1.35% | +10.50% | -1.73% | +28.11% | -57.46% | 738M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ZYME Stock
- Charts Zymeworks Inc.
- Comparison Chart
